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Introduction
 Lymphoma is a malignant neoplasm of the lymphoid 
tissue; it is broadly classified into Hodgkin lymphoma 
(HL) and non-Hodgkin lymphoma (NHL) depending 
on the presence or absence of the Reed-Sternberg cells. 
Non-Hodgkin lymphoma is further sub classified into B 
or T-cell types. Generally NHL is more common than 
HL representing about 92.1%, of these; the B-cell type 
accounts for 75% (Sukpanichnant, 2004). In the oral 
cavity NHL represent only 3.5% of all oral malignancies 
(Epstein et al., 2001). In this study we report a series of 
36 cases of oral extranodal NHL and sub classify them 
into the B-cell and T-cell type. 
 Lymphomas usually involve lymph nodes; however 
24% of the NHL occur in extranodal sites, quarter of 
these occur in the head and neck region (Piatelli et al., 
1997). In a study of 1467 cases of NHL; 28% were found 
in head and neck (Freeman et al., 1972). Extranodal NHL 
is uncommon in the oral cavity with a percentage range 
from 2% (Freeman et al., 1972) to 8% (Shah et al., 2011), 
and often involves the central nervous system (Padhi et 
al., 2012).
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Abstract
 Background: Lymphoma is a malignant neoplasm of lymphoid tissue classified into Hodgkin’s and non-
Hodgkin’s types. It mostly affects lymph nodes although a considerable proportion of Non-Hodgkin’s cases 
occur in extranodal sites. Materials and Methods: Selected cases diagnosed as non-Hodgkin’s lymphoma (NHL) 
during the period of 1980 to 2012 were retrieved from the archives of the Oral Pathology Diagnostic Laboratory, 
Faculty of Dentistry, University of Malaya. The sections from the formalin-fixed paraffin embedded tissue blocks 
were stained with H&E as well as with LCA, CD20, and CD3. Results: The mean age was 41.6 years with a 
male: female ratio of 1.3:1. Out of the forty two cases, nineteen were Malays, eighteen were Chinese, followed 
by Indians (3) and Indonesians (2). The most common site of involvement was the mandible (22.2%), followed 
by the maxilla and palate (19.4% each). Most of the lesions presented as a painless progressive swelling. Only 
thirty six cases were further subdivided into B or T cell types. The majority were B-cell type (26 cases), of these 6 
cases were Burkitt’s lymphomas. Only ten cases were T-cell lymphoma, with three cases of NK/T-cell lymphoma. 
Conclusions: In this series of 42 patients diagnosed as extranodal non-Hodgkin’s lymphoma, the lesions appeared 
as painless swellings, mostly in men with the mandible as the most frequent site of involvement. Majority were 
B-cell lymphomas with Malays and Chinese being equally affected whereas lymphomas were rare in the Indian 
ethnicity. T-cell lymphomas were found to be common in the Chinese ethnic group. 
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 Selected cases (42 cases) diagnosed as Non-Hodgkin’s 
lymphoma (NHL) during the period of 1980 to 2012 
were retrieved from the archives of the Oral Pathology 
Diagnostic Laboratory, Faculty of Dentistry, University 
of Malaya. Only cases with complete demographic and 
site data were selected. Clinical data of these patients 
were obtained from the clinical files. New sections 
were made and stained with Hematoxylin and Eosin (H 
and E) and first examined by one of the author (RBZ). 
They were subsequently reconfirmed as lymphoma 
by immunopositivity to leukocyte common antigen 
(LCA) and the proliferation index was measured by Ki-
67. Thirty six cases had sufficient material for further 
immunophenotyping into T- or B-cell categories. The 
T-cell phenotype was determined by tumor cell expression 
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of CD3 or CD45O and the absence of B-cell antigens 
CD20 (L26), or CD79a, and B-cell phenotype determined 
vice versa.
Results 
 This series consisted of forty two patients with the 
diagnosis of extranodal NHL of the oral cavity. The 
clinical and pathological data of all cases are shown in 
Table 1. The majorities were males (24 cases) and the 
rests were females (18 cases), with a male: female ratio 
of 1.3:1 Their ages ranged from 2 to 90 years old with a 
mean age of 41.6 years and median age of 47 (IQR 14-63) 
years. The cases were almost equally distributed between 
Malay (19) and Chinese (18), and the rest were made of 
Indian (3 cases) and 2 Indonesians.
 The mandible (9 cases) was the most commonly 
involved site with NHL, followed by the cheek (8 cases) 
then the palate and maxilla (7 cases each). Four cases were 
in the salivary glands, and one of them involves both the 
parotid and submandibular glands. Three of the salivary 
gland tumors were in Malay. Soft palate and gingiva 
constitute ywo cases each. And one case for tongue, lip, 
and foor of the mouth.
 Most patients reported with painless progressive 
swelling. One of the patients (case no. 18) had a recurrent 
NHL which had been treated with chemotherapy; and 
another patient (case no. 1) had a metastatic tumor in 
the mandible with the primary tumor in the thymus and 
thoracic vertebrae. Immunohistochemical examination 
was performed in 36 of the 42 cases, and more than two 
third (26 case) were diagnosed as B-cell lymphoma of 
these 6 cases (23.07%) were Burkitt’s lymphomas and 
only ten cases were diagnosed as T-cell lymphoma, with 
three cases of NK/T-cell lymphoma.
 There was equal distribution of the B-cell lymphomas 
between males and females (13 case each), however 8 out 
of the ten cases of T-cell lymphomas were in males (Table 
2). About 60% of the T-cell lymphomas were in Chinese, 
while the B-cell lymphomas was frequently encountered 
in Malay (46%) and the two Indian cases were B-cell 
lymphomas. The mean age of the B-cell lymphomas 
(46.2±24) is higher than the T-cell lymphomas (38.9±22). 
Four cases with Burkitt’s lymphomas were below 15 years 
old and two patients over 60 years old.
 About 66.6% of the lesions were in the soft tissue, of 
these 70.8% were of the B-cell phenotype. All the seven 
mandibular, and the two gingival tumors were of the 
B-cell type. Nine out of the ten T-cell lymphomas were 
equally distributed between the palate, the maxilla, and 
the cheek (3 cases each). There were only three NK/T-cell 
lymphomas in this series; two of wich occurred in the 
hard palate. There was one rare case of lymphoma of the 
tongue however, the exact phenotype of this patient was 
not determined due to insufficient tissue.
 B-cell lymphoma: The cases of the B-cell phenotype 
show a diffuse infiltration of malignant cells with scanty 
cytoplasm; these cells are small round with dark nuclei and 
occasional mitosis in few cases (case no. 10, 18, and 19), 
the remainder of the cases demonstrates a medium to large 
size cells with round to oval nuclei and vesicular nuclei, 
Table 2. Distribution of The Type of Lymphoma 
According to Gender Ethnicity and Site
 Type of lymphoma
 B-cell lymphoma     T-cell lymphoma Total
Gender Male 13 (61.9%) 8 (38.1%) 21
 Female 13 (86.7%) 2 (13.3%) 15
Ethnicity Malay 12 (80.0%) 3 (20.0%) 15
 Chinese 11 (64.7%) 6 (35.3%) 17
 Indian 2 (100%) 0 (00.0%) 2
 Indonesian 1 (50.0%) 1 (50.0%) 2
Site Soft tissue 17 (70.8%) 7 (29.2%) 24
 Bone 9 (75.0%) 3 (25.0%) 12
Table 1. Clinical and Pathological Data of Forty Two 
Patients Diagnosed as NHL
No. Age Gender Ethnicity Site Typ of Lymphoma
1 15 M Malay Mandible Lymphoma
2 9 M Chinese Mandible B-cell lymphoma
     (Burkitt’s)
3 44 F Chinese Mandible B-cell lymphoma
4 70 M Malay Lip B-cell lymphoma
5 56 M Malay Palate B-cell lymphoma
6 59 M Malay Tongue Lymphoma
7 58 M Indian Gingiva B-cell lymphoma
8 11 F Indian Mandible B-cell lymphoma
     (Burkitt’s)
9 30 M Malay Cheek  B-cell lymphoma
10 57 F Malay Mandible  Lymphoma
11 11 M Chinese Maxilla  T-cell lymphoma
12 39 M Chinese Maxilla B-cell lymphoma
     (Diffuse large)
13 71 M Chinese Mandible  B-cell lymphoma
14 7 F Indian Cheek Lymphoma
15 48 M Chinese Palate  T-cell lymphoma
16 50 F Chinese Maxilla  T-cell lymphoma
17 65 M Chinese Palate NK/T-cell lymphoma
18 70 F Chinese Palate B-cell lymphoma
19 11 F Malay Mandible  B-cell lymphoma
20 31 F Malay Cheek T-cell lymphoma
21 90 M Malay Soft palate B-cell lymphoma
22 66 M Malay Palate B-cell lymphoma
23 68 F Chinese Palate B-cell lymphoma
24 59 F Malay Parotid and B-cell lymphoma
     submandibular
25 48 M Chinese Cheek T-cell lymphoma
26 65 F Malay Submandibular B-cell lymphoma
     (Burkitt’s)
27 63 M Malay Cheek B-cell lymphoma
     (Burkitt’s)
28 29 M Indonesian Palate  NK/T-cell lymphoma
29 11 F Chinese Mandible  B-cell lymphoma
30 12 M Chinese Gingiva  B-cell lymphoma
     (Burkitt’s)
31 33 F Chinese Cheek B-cell lymphoma
     (Diffuse large)
32 73 M Malay Maxilla T-cell lymphoma
33 73 M Malay Maxilla B-cell lymphoma
34 18 F Chinese Maxilla Lymphoma
35 2 M Malay Maxilla Lymphoma
36 49 F Malay Submandibular B-cell lymphoma
37 32 M Chinese Floor of the mouth T-cell lymphoma
38 49 F Chinese Submandibular region B-cell lymphoma
39 4 M Malay Mandible B-cell lymphoma
     (Burkitt’s)
40 44 M Chinese Cheek B-cell lymphoma
     (Diffuse large)
41 2 M Malay Cheek NK/T-cell lymphoma
42 48 F Indonesian Soft palate B-cell lymphoma
*Female: F; Male: M
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prominent nucleoli, and frequent mitosis. Four cases (case 
no. 12, 29, 31, and 40) of the large cell type were Bcl-2 
positive, CD10 and cyclin D1 negative, this allow further 
classification as diffuse large B-cell lymphoma.
 The histopathology of the Burkitt’s lymphoma cases 
(case no. 2, 8, 26, 27, 30, and 39) shows diffuse infiltrating 
sheets of uniform small neoplastic cells, with a thin rim 
of cytoplasm. The nuclei of these tumor cells were non-
cleaved, round with several prominent nucleoli. Mitoses 
were abundant together with interspersed histiocytes 
imparting the classical starry sky appearance (Figure 1). 
Diffuse LCA and CD20 immunoreactivity, and very high 
Table 3. Case Series of Oral Extranodal Non Hodgkin’s Lymphoma (Case Series Having 6 or More Cases are Included 
in This Table)







Site B- or T-cell lymphoma
Hashimoto and Kurihara 
(1982)
9 3-87 7/2 B-cell lymphoma-8 (89%)
Unclassified-1 
Eisenbud et al. 
(1983; 1984)
31 3-89 14/17 Maxilla-9                      Mandible-5
Palate-10                      Cheek-1
Tongue-1
Floor of the mouth-1
Retro molar trigon-1
Large B-cell lymphoma-9 (29%)
Stoolweg et al. (1985) 20
Takahashi et al. (1987) 11 19-78 6/5 Palate-3                        Gingiva-4
Cheek-4
Diffuse Large B-cell lymphoma-8
Diffuse mixed type lymphoma-2
Burkitt’s lymphoma-1
Handlers et al. (1986)
34 16/18
Vestibule, gingiva, mandible, soft 
palate and maxilla are commonsites.
B-cell lymphoma-31 (91%)
Howell et al. (1987)
Fukada et al. (1987) 20 11-80
51 
(Median)
12/8 Gingiva-11                   Cheek-2
Mandible-3
Floor of the mouth-3    Lip-1
Diffuse large B-cell lymphoma-15 (75%)
T-cell lymphoma-2 (10%)
Histiocytosis-3 (15%)
Wolvius et al. (1994) 34
Nocini et al. (2000) 10 51 3/2 Large B-cell lymphoma-10 (100%)
Epstine et al. (2001) 57 28/29 Tongue-30                    Palate-17
Gingiva-7                     Lip-3
Large cell and small cell lymphomas
B-cell lymphoma-92%
T-cell lymphoma-8%
Solomides et al. (2002) 71 1-2 B-cell lymphoma-92%
T-cell lymphoma-8%
Van der Waal (2005) 40 3-88 
59 
(Mean)
24/16 Upper jaw-20               Lower jaw-7
Cheek-6                       Tongue-6
B-cell lymphoma-100%
Large B-cell-20 (50%)
Djavanmardi et al. (2008) 15 Law
Kemp et al. (2008) 40 71 years 
(Mean)
47/53 B-cell lymphoma-98%
Shah et al. (2011) 15 42.6 
years 
(Median)
3:2 ratio Gingivobuccal complex-12
Labial mucosa-1
Cheek-1                        Tongue-1
Figure 1. A) Photomicrograph of Burkitt’s 
Lymphoma Showing Small Round Cells with 
Scanty Cytoplasm and Multiple Small Nuclei 
Interspersed by Macrophages (H and E Stain, 
Magnification 10X); B) Photomicrograph Showing 
Ki-67 Labeling Index was 100% (Magnification 10X)
A)            B)
Figure 2. A) Photomicrograph Showing B-Cell 
Lymphoma. Tumor Cells Contain Large Non-Cleaved Nuclei 
With Coarse Chromatin Distribution, Prominent Nucleoli, and 
Frequent Mitotic Figures. (H&E Stain, Magnification 20X); B) 
Photomicrograph Demonstrating Diffusely Positive 
for Anti-CD20 Antibody (Magnification 10X); (C) 
Photomicrograph Demonstrating Patchy Immune-
Stain of Anti-CD3 Antibody (Magnification 10X)
 









A)                B)                            C)
Ki-67 labeling index were also observed.
T-cell lymphoma
 The seven cases of T-cell type show a diffuse 
infiltration by small round cells with minimal cytoplasm 
and dark staining nuclei. However the NK/T-cell cases 
(case no. 17, 28, and 41) demonstrates large pleomorphic 
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approximately 2-5% of salivary gland neoplasms and 
Triantafillidon et al. (2012) reported 41% (24 cases) 
involving the salivary glands. Parotid gland was the 
most frequently affected among the salivary glands 
(Weber et al., 2003). In this study, three cases were in the 
submandibular gland with one case involving both the 
submandibular and parotid gland. Previous report stated 
that the buccal mucosa were rarely involved by NHL 
(Handlers et al., 1986; Howell et al., 1987; Zanakis et 
al., 1992) however in this series 19.1% of the cases were 
in the cheek.
The majority of the oral cavity lymphomas are of 
B-cell type, Kemp et al. (2008) reported a 98% in their 
study as B-cell lymphomas while, van der Waal et 
al.(2005) found all his patients to be of the B-cell type 
however, in the present study, we report 72.2% to be of 
B-cell origin.
An EBV-associated lymphomas that occurs commonly 
in Chinese is Burkitt’s lymphoma which in a previous 
study from University Malaya accounted for 100% 
occurrence in this group (Peh, 2001), nevertheless in this 
study; 3 of the cases occur in Malay and two cases were 
in Chinese and one case in Indian ethnicity. Burkitt’s 
lymphoma is a high-grade, aggressive type of NHL, it 
accounts for 3-5% of all lymphomas (Solomides et al., 
2002). Three subtypes of Burkitt’s lymphoma have been 
recognized: (1) African (endemic) Burkitt’s lymphoma; 
(2) American (sporadic) Burkitt’s lymphoma; and (3) 
HIV-associated Burkitt’s lymphoma. In endemic regions; 
Burkitt’s lymphoma accounts for nearly half of all 
childhood malignancies (Solomides et al., 2002). In this 
study 6 cases were diagnosed as Burkitt’s lymphoma, 
four of them (66.6%) occured in patients ≤15 years of age 
and accounts for 36.4% of all children in this study, this 
comes in line with an earlier Malaysian study of childhood 
malignancies which stated that Burkitt’s lymphoma is 
the second most common lymphoma in children (Peh et 
al., 2004).
Only 8% of oral extranodal lymphomas were of the 
T-cell type (Epstein et al., 2001; Solomides et al., 2002), 
however the percentage of T-cell lymphomas in this series 
is quite high (27.8%), of these 60% were in Chinese. The 
reason for this high percentage is unknown but may be 
due to that 43.9% of the cases in this series were Chinese 
and it is reported that there is a higher prevalence of EBV-
associated lymphomas namely NK/T-cell lymphoma in the 
Chinese when compared to other ethnic group (Howell 
et al., 1987). 
The mainstream treatment of diffuse large B-cell 
lymphoma is chemotherapy. The CHOP regimen is 
most widely used which consists of cyclophosphomide, 
hydrodaunorubicin, vincristin and prednisolone. It is given 
in either 2, 3 or 4 weekly cycles for 6 to 8 courses. The 
R-CHOP regimen includes anti-CD20 (rituxianab) which 
improves the cure rate. Combined radiotherapy along 
with chemotherapy may be optimal therapy for localized 
disease. Ifosfamide, epirubicin and etoposide (IVE) are 
used in cases of relapse and which are chemosensitive. 
Another regimen that is used in cases of relapse and 
chemosensitive cases is etoposide, cytosine, arabinoside, 
methylprednisolone and cisplatin (ESHAP). In cases of 
Discussion
The first case series of extranodal NHL of oral cavity 
(30 cases) was published in 1972 by Freeman et al. 
(1972). Hashimoto and Kurihara (1982) and the largest 
case series of extranodal NHL of oral cavity (71 cases) 
was by Solomides et al. (2002) (Table 3). In this study 42 
cases of extranodal NHL of oral cavity is reported. Van der 
Waal et al. (2005) published a series (40 cases) of primary 
extranodal NHL of the oral cavity in which males were 
most commonly affected. This male predominance was 
noted in other series (Table 3), however Kemp et al. (2008) 
found 53% of these tumors in females and is also observed 
in other series (Table 3). In this study the majority of 
cases were in males with a male: female ratio of 1.3:1. 
This ratio is smaller than the 2.4:1 ratio reported by a 
previous study of lymphoma carried out at the Department 
of Pathology, University of Malaya, however that study 
described lymphomas from all over the body (Peh, 2001). 
The median age is 47 years, with previous case series of 
oral NHL reporting a mean of 59 (van der Waal et al., 
2005) and 42.6 years (Shah et al., 2011).
In Malaysia, the NHL occurs more commonly in 
Chinese (22.51-79%) followed by those of Malay (5-
16.37%) and lastly Indians (2.5-16%) (Peh, 2001; Peh 
et al., 2004). However, in this study, there was equal 
distribution between Malay and Chinese (43.9%). The 
occurance of NHL in Indians has been reported to be 
rare (Shah et al., 2011) which was also reflected in this 
study (2 cases). 
The most common site involved in oral cavity is 
palate and gingiva (Takahashi et al., 1987; Shah et al., 
2011) in this series the palate and gingiva represent about 
17.7 and 4.8% of the lesions respectively. It was reported 
that 15-45% of intra-oral NHL occurs in the jaws, with 
the mandible being the less frequent site. Larson et al. 
(1984) studied 100 patients with extra nodal lymphoma 
of the head and neck and non involved the mandible. 
Eisnbound et al. (1983; 1984) in their study of 31 case of 
oral NHL found 14 patients with bone involvement, only 
5 of them were in the mandible. However, Pazoki et al. 
(2003) reported 3 mandibular and 1 maxillary intrabony 
NHLs, and Etemad-Moghadam et al. (2010) found 
that the mandibular lesion exceed the maxillary. In this 
study 38.1% of the tumors were intra-bony however the 
mandible was more affected than the maxilla and other 
oral cavity sites.
Lymphomas of the salivary glands accounts for 
Figure 3. A) Photomicrograph Showing T-Cell 
Lymphoma, with Tumor Cells Having Medium-
Size Nuclei (H and E Stain, Magnification 20X); B) 
Photomicrograph Demonstrating Tumour Negative 
Immune-Stain of Anti-CD20 Antibody (Magnification 
20X); C) Photomicrograph Demonstrating Positivity 
for The T-Cell Marker (Anti-CD3 Antibody) 
(Magnification 20X)
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primary refractory or chemoresistant disease the prognosis 
is poor and there are various drug trial being carried out. 
Alemtuzumab may be used in both B-and T-cell NHL. 
The prognosis of Burkitt’s lymphoma was poor until 
the introduction of chemotherapy regimens such as high 
dose of methotrexate and cyclophosphamide (Hoffbrand 
et al., 2006).
In conclusion, we herein described a series of forty 
two patients diagnosed as extranodal Non-Hodgkin’s 
lymphoma of the oral cavity. These lesions generally 
appear as a painless swelling and they mostly occur 
in men. The mandible is the most frequent site of 
involvement. The majority of cases were lymphomas of 
B-cell with Malays and Chinese being equally affected 
whereas lymphomas were rare in Indian ethincity.
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